Jan 9, 2017 9:45 am EST BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease
Sep 12, 2016 9:45 am EDT BioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease
Jul 13, 2016 10:47 am EDT BioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course
Jun 28, 2016 9:45 am EDT BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
May 31, 2016 9:45 am EDT BioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference
May 23, 2016 9:45 am EDT BioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders
Feb 23, 2016 9:45 am EST BioRestorative Therapies Deepens Board of Directors With Addition of Robert B. Catell, Former Chairman and CEO of KeySpan Corporation and Chairman of National Grid, US
Feb 9, 2016 8:00 am EST BioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic Product
Dec 2, 2015 8:00 am EST BioRestorative Therapies Appoints John M. Desmarais, J.D. to Its Board of Directors